Intracellular Net Debt from 2010 to 2025

ITCI Stock

USD 126.20 0.06 0.05%

Intracellular's Net Debt is decreasing with slightly volatile movements from year to year. Net Debt is estimated to finish at about -111.9 M this year. Net Debt is the total debt of Intracellular Th minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2013-03-31

Previous Quarter

-676.8 M

Current Value

-446.6 M

Quarterly Volatility

117.7 M

Yuan Drop

Covid

Check Intracellular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intracellular's main balance sheet or income statement drivers, such as Interest Expense of 8.9 M, Total Revenue of 560.7 M or Gross Profit of 520 M, as well as many indicators such as Price To Sales Ratio of 16.16, Dividend Yield of 0.0 or PTB Ratio of 7.67. Intracellular financial statements analysis is a perfect complement when working with Intracellular Valuation or Volatility modules.

Check out the analysis of Intracellular Correlation against competitors.

Latest Intracellular's Net Debt Growth Pattern

Below is the plot of the Net Debt of Intracellular Th over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Intracellular's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intracellular's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Intracellular Net Debt Regression Statistics

	Arithmetic Mean	(63,363,491)
	Geometric Mean	51,923,328
	Coefficient Of Variation	(62.46)
	Mean Deviation	32,534,929
	Median	(48,642,225)
	Standard Deviation	39,577,972
	Sample Variance	1566.4T
	Range	111.7M
	R-Value	(0.85)
	Mean Square Error	455.7T
	R-Squared	0.73
	Significance	0.000026
	Slope	(7,095,148)
	Total Sum of Squares	23496.2T

Intracellular Net Debt History

	2025	-111.9 M
	2024	-117.7 M
	2023	-130.8 M
	2022	-128.6 M
	2021	-67 M
	2020	-30.9 M
	2019	-84.5 M

Other Fundumenentals of Intracellular Th

Net Debt To E B I T D A

Intracellular Net Debt component correlations

	Total Assets	Total Stockholder Equity	Accounts Payable	Short Term Investments	Total Liab	Common Stock	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Net Receivables	Capital Surpluse	Total Current Assets	Deferred Long Term Liab	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock	Short Term Debt
Total Assets		0.92	0.77	0.85	0.85	0.39	0.22	1.0	0.69	-0.75	-0.89	0.78	0.96	0.94	0.77	-0.54	0.6	0.56	0.81	0.61
Total Stockholder Equity	0.92		0.63	0.95	0.65	0.38	0.21	0.93	0.66	-0.63	-0.78	0.56	0.83	1.0	0.84	-0.2	0.61	0.58	0.74	0.53
Accounts Payable	0.77	0.63		0.51	0.84	0.33	0.26	0.74	0.66	-0.79	-0.85	0.73	0.85	0.67	0.75	-0.53	0.21	0.14	0.69	0.46
Short Term Investments	0.85	0.95	0.51		0.46	0.25	0.2	0.87	0.64	-0.4	-0.62	0.35	0.7	0.93	0.81	-0.13	0.51	0.5	0.53	0.47
Total Liab	0.85	0.65	0.84	0.46		0.5	0.24	0.82	0.52	-0.88	-0.94	0.95	0.95	0.7	0.6	-0.7	0.5	0.42	0.91	0.54
Common Stock	0.39	0.38	0.33	0.25	0.5		0.18	0.36	-0.13	-0.35	-0.51	0.48	0.46	0.4	0.32	-0.17	0.44	0.4	0.61	0.32
Property Plant Equipment	0.22	0.21	0.26	0.2	0.24	0.18		0.19	0.21	-0.16	-0.4	0.08	0.33	0.23	0.35	-0.02	-0.08	-0.09	0.29	0.47
Net Tangible Assets	1.0	0.93	0.74	0.87	0.82	0.36	0.19		0.7	-0.72	-0.85	0.75	0.94	0.94	0.77	-0.53	0.6	0.56	0.79	0.57
Current Deferred Revenue	0.69	0.66	0.66	0.64	0.52	-0.13	0.21	0.7		-0.61	-0.57	0.4	0.64	0.67	0.67	-0.31	0.14	0.11	0.42	0.31
Net Debt	-0.75	-0.63	-0.79	-0.4	-0.88	-0.35	-0.16	-0.72	-0.61		0.87	-0.85	-0.85	-0.68	-0.6	0.47	-0.36	-0.29	-0.78	-0.52
Retained Earnings	-0.89	-0.78	-0.85	-0.62	-0.94	-0.51	-0.4	-0.85	-0.57	0.87		-0.83	-0.97	-0.83	-0.76	0.46	-0.5	-0.43	-0.91	-0.68
Net Receivables	0.78	0.56	0.73	0.35	0.95	0.48	0.08	0.75	0.4	-0.85	-0.83		0.86	0.61	0.41	-0.74	0.6	0.53	0.88	0.46
Capital Surpluse	0.96	0.83	0.85	0.7	0.95	0.46	0.33	0.94	0.64	-0.85	-0.97	0.86		0.86	0.75	-0.6	0.54	0.49	0.89	0.66
Total Current Assets	0.94	1.0	0.67	0.93	0.7	0.4	0.23	0.94	0.67	-0.68	-0.83	0.61	0.86		0.85	-0.24	0.62	0.58	0.78	0.56
Deferred Long Term Liab	0.77	0.84	0.75	0.81	0.6	0.32	0.35	0.77	0.67	-0.6	-0.76	0.41	0.75	0.85		-0.12	0.18	0.13	0.57	0.4
Long Term Investments	-0.54	-0.2	-0.53	-0.13	-0.7	-0.17	-0.02	-0.53	-0.31	0.47	0.46	-0.74	-0.6	-0.24	-0.12		-0.27	-0.24	-0.48	-0.27
Net Invested Capital	0.6	0.61	0.21	0.51	0.5	0.44	-0.08	0.6	0.14	-0.36	-0.5	0.6	0.54	0.62	0.18	-0.27		0.99	0.73	0.49
Net Working Capital	0.56	0.58	0.14	0.5	0.42	0.4	-0.09	0.56	0.11	-0.29	-0.43	0.53	0.49	0.58	0.13	-0.24	0.99		0.65	0.52
Capital Stock	0.81	0.74	0.69	0.53	0.91	0.61	0.29	0.79	0.42	-0.78	-0.91	0.88	0.89	0.78	0.57	-0.48	0.73	0.65		0.57
Short Term Debt	0.61	0.53	0.46	0.47	0.54	0.32	0.47	0.57	0.31	-0.52	-0.68	0.46	0.66	0.56	0.4	-0.27	0.49	0.52	0.57

Click cells to compare fundamentals

About Intracellular Financial Statements

Investors use fundamental indicators, such as Intracellular's Net Debt, to determine how well the company is positioned to perform in the future. Although Intracellular's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Net Debt	-117.7 M	-111.9 M
Net Debt To EBITDA	0.95	0.76

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:

How To Invest In Intracellular

Details

Is Intracellular Stock a good investment?

Details

What is Intracellular's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Intracellular Correlation against competitors.

You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.87)

Revenue Per Share

6.096

Quarterly Revenue Growth

0.39

Return On Assets

(0.07)

Return On Equity

(0.1)

The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Intracellular Net Debt from 2010 to 2025

Latest Intracellular's Net Debt Growth Pattern

Intracellular Net Debt Regression Statistics

Intracellular Net Debt History

Other Fundumenentals of Intracellular Th

Intracellular Net Debt component correlations

About Intracellular Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY